Caplight Directory>Companies>Perceive Pharma-preview>Perceivepharma


Perceive Pharma

Perceive Pharma

Private
South San Francisco, CaliforniaN/Ahttp://perceivepharma.com/

Last Round

Series A

Feb 18, 2025

Est. Valuation

$169M

Total Funding Raised

$15M

Company Overview

Perceive Pharma is a drug discovery company that is advancing novel small molecule neuroprotective therapeutics, with lead pipeline programs in glaucoma and other ophthalmic diseases.

Keywords

neuroprotective therapeuticssmall molecule drugsglaucoma treatmentophthalmologybiopharmaretinal neuroprotectionIOP-independent therapydrug discoverydrug developmentclinical stage pharmafirst-in-class drugpharma licensinggenomic screeninglife science incubator

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Perceive Pharma Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Perceive Pharma Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 18, 2025
Series AAug 1, 2018
View all Funding Rounds

Perceive Pharma Investors

Notable investors and investment history

InvestorRounds
Retinal Degeneration FundSeries A
Deerfield ManagementSeries A
GVSeries A
BraidwellSeries A
Catalio Capital ManagementSeries A
Johnson & Johnson Innovation - JJDCSeries A
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 18, 2025

    $15M round led by Deerfield Management

  • Aug 1, 2018

    Deerfield Management led the Series A round.

View all signals

Perceive Pharma Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Perceive Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Perceive Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Year Founded2025
Last FundingFeb 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.